Concepedia

Nikolaos Ioannou

NI

14

Publications

722

Citations

12

H-Index

2011

Active since

Affiliations

King's College London(Current)

Kingston University

St George's, University of London

Stanford University

Karolinska Institutet

Nikolaos Ioannou is an author at King's College London specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2011–2023

14

Publications

14

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

Alison Halliday, Richard Bulbulia, Leo H. Bonati et al. · The Lancet · 2021 · 290 citations · Full text

Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity

Bola S. Hanna, Laura Llaó Cid, Murat Iskar et al. · Immunity · 2021 · 115 citations · Full text

, , +10

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells

Nikolaos Ioannou, Angus Dalgleish, Alan M. Seddon et al. · British Journal of Cancer · 2011 · 72 citations · Full text

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy

Nikolaos Ioannou, Patrick R. Hagner, Matt Stokes et al. · Blood · 2020 · 48 citations · Full text

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Nikolaos Ioannou, Alan M. Seddon, Angus Dalgleish et al. · BMC Cancer · 2013 · 46 citations · Full text

Rows per page

1–5 of 14